ECR 2014: Future of molecular imaging is now

VIENNA—Today marked the opening of the European Congress of Radiology (ECR) 2014 being held March 6-10 at the Austria Center Vienna. This is the 20th annual meeting of the European Society of Radiology (ESR), where an estimated 20,000 participants from 100 countries have come together to discuss the latest news and developments in the worldwide radiological community.

Molecular imaging is a major focus in the program this year, with topics ranging from investigational biomarkers and companion diagnostics; advancements in molecular MRI; applications and challenges concerning hybrid imaging, including PET/MR, PET/CT and SPECT; and techniques in specialties like neuroimaging, oncology and cardiac imaging. 

“People are saying that molecular imaging is the future of radiology, but actually it is already the present of radiology and its future,” said Valentin E. Sinitsyn, MD, PhD, congress president for ECR 2014 and head of the department of radiology at the Federal Center of Medicine and Rehabilitation in Moscow, during the live press conference.

This year also is being dubbed “the year of the brain,” with many presentations focusing on cutting-edge neuroimaging. The meeting serves as a major technological tradeshow featuring 300 exhibitors representing the gamut of medical imaging technology.

Follow select scientific sessions and industry news highlighted by Molecular Imaging on site in Vienna as ECR 2014 progresses.

 

 

 

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.